1 results match your criteria: "University of Insubria - ASST Lariana[Affiliation]"
Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
Thromb Res
December 2021
Department of Medicine and Surgery, University of Insubria - ASST Lariana, San Fermo della Battaglia (Como), Italy.
Background: Cyclin-dependent kinase inhibitors (CDKIs) may increase the risk of thrombotic events of endocrine therapy (ET) in women with hormone-sensitive, HER2-negative advanced breast cancer (BC). Aim of our systematic review is the estimate of the risk of venous and arterial thromboembolism in women with advanced BC treated with CDKIs in phase III randomized controlled trials (RCTs).
Methods: Studies were identified by electronic search of MEDLINE, EMBASE and CENTRAL database until October 2021.